Therefore, the functional analyses employing flow cytometry suggest that FOSL1 serves as an oncotarget in GBM, stimulating the growth and proliferation of glioma cells possibly by inhibiting cell apoptosis and promoting their cell entry into the S and G2/M phases of the cell cycle. This evidence concerns the gene FOSL1 and glioma.